AbbVie Profit Margin

The latest profit margin for 4AB.DU is 9.82% as of June 2026. That compares with 6.45% in the prior-year period — up 52.1% year over year. That is below the Healthcare sector average of 10.58%. Investors often review this figure alongside AbbVie's historical trend and sector peers before judging valuation or financial health.

Over the past year, 4AB.DU's profit margin moved from 6.45% to 9.82% — a 52.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in AbbVie's valuation or profitability profile.

Against Healthcare companies, 4AB.DU currently prints 9.82% for profit margin, while the sector average sits near 10.58%. That is roughly 7.2% below the sector mean. Large gaps often invite a closer look at AbbVie's growth, margins, and balance sheet.

Profit Margin shows how effectively AbbVie converts resources into returns. At 9.82%, 4AB.DU may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 6.45% in the prior-year period — up 52.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 4AB.DU's profit margin (9.82%), review year-over-year change from 6.45%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.